HB 648-FN is a legislative bill aimed at improving health insurance coverage for individuals with diabetes by mandating that health insurance providers cover glucose monitoring devices and related supplies. The bill introduces several key provisions, including a cap of $30 on copayments for a 30-day supply of insulin prescriptions, which will not be subject to deductibles. It also ensures that coverage for glucose monitoring devices, such as continuous glucose monitoring systems (CGMS), is provided without requiring prior authorization or referrals. The bill amends existing laws to include coverage for medically necessary outpatient self-management training and educational services related to diabetes, as well as insulin and necessary diabetes treatment equipment.

Additionally, the bill modifies current law by inserting definitions and stipulations that coverage should not depend on the frequency of insulin use or blood glucose testing. It deletes references to "pharmacy" in the context of coverage, thereby broadening the scope of covered diabetes-related supplies and services. To maintain coverage, patients are required to engage in follow-up care with their healthcare provider at least once every six months during the first 18 months of monitoring and annually thereafter. The bill does not allocate funding or authorize new positions, and its fiscal impact remains indeterminable, with potential implications for insurance premiums and health plan costs. The effective date of the act is set for 60 days after its passage.

Statutes affected:
Introduced: 415:6-e, 415:18-f, 420-A:17-a, 420-B:8-k